InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+91.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Desjardins Clarissa, Director. Director active across 3 companies, notably INSMED Inc. Aggregated, 9 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €112k. History available since 20 May 2025. The latest transaction was filed on 20 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
3,305 sharesCommon StockSEC:0001793390-26-000002:0
3,305 sharesCommon StockSEC:0001793390-26-000002
1,895 shares@ US$66.87100.0% of flowCommon StockSEC:0001628280-25-027340:0
Ideal exit: 14 Feb 2026 (T+270)
5,058 sharesCommon StockSEC:0001628280-25-026567:0
13,162 sharesCommon StockSEC:0001628280-24-023562:0
13,192 sharesCommon StockSEC:0001628280-23-018201:0
14,645 sharesCommon StockSEC:0001140361-22-019181:0
7,558 sharesCommon StockSEC:0001140361-21-017415:0
7,558 sharesCommon StockSEC:0001140361-21-017415
9 of 9 declarations
About Desjardins Clarissa
Clarissa Desjardins is a Board Member at INSMED Inc. She contributes to the company's governance and strategic decision-making. Desjardins is recognized for her expertise in the biopharmaceutical sector and her commitment to innovation. Her role is essential in guiding INSMED toward sustainable and responsible growth.
